An old drug gets a new price: $89,000 a year
Consumer Corner February 12, 2017 Washington Post 0
An old steroid treatment, long available outside the United States, received approval this week for a rare disease that afflicts about 15,000 Americans. The new list price for the drug? $89,000 a year.
Where do we stand on COVID?
Jul 11, 2021 0
The spike in RSV cases
Jul 11, 2021 0
Georgia health rankings
Jun 25, 2021 0
No comments so far.
Be first to leave comment below.